chr12-117222765-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_000620.5(NOS1):c.3925G>A(p.Val1309Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000118 in 1,613,864 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000089 ( 1 hom. )
Consequence
NOS1
NM_000620.5 missense
NM_000620.5 missense
Scores
8
11
Clinical Significance
Conservation
PhyloP100: 5.04
Genes affected
NOS1 (HGNC:7872): (nitric oxide synthase 1) The protein encoded by this gene belongs to the family of nitric oxide synthases, which synthesize nitric oxide from L-arginine. Nitric oxide is a reactive free radical, which acts as a biologic mediator in several processes, including neurotransmission, and antimicrobial and antitumoral activities. In the brain and peripheral nervous system, nitric oxide displays many properties of a neurotransmitter, and has been implicated in neurotoxicity associated with stroke and neurodegenerative diseases, neural regulation of smooth muscle, including peristalsis, and penile erection. This protein is ubiquitously expressed, with high level of expression in skeletal muscle. Multiple transcript variants that differ in the 5' UTR have been described for this gene but the full-length nature of these transcripts is not known. Additionally, alternatively spliced transcript variants encoding different isoforms (some testis-specific) have been found for this gene.[provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), NOS1. . Gene score misZ 3.6832 (greater than the threshold 3.09). Trascript score misZ 4.7179 (greater than threshold 3.09). GenCC has associacion of gene with idiopathic achalasia.
BP4
Computational evidence support a benign effect (MetaRNN=0.16351256).
BS2
High AC in GnomAd4 at 6 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NOS1 | NM_000620.5 | c.3925G>A | p.Val1309Ile | missense_variant | 26/29 | ENST00000317775.11 | NP_000611.1 | |
NOS1 | NM_001204218.2 | c.4027G>A | p.Val1343Ile | missense_variant | 27/30 | NP_001191147.1 | ||
NOS1 | NM_001204213.2 | c.2917G>A | p.Val973Ile | missense_variant | 25/28 | NP_001191142.1 | ||
NOS1 | NM_001204214.2 | c.2917G>A | p.Val973Ile | missense_variant | 25/28 | NP_001191143.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NOS1 | ENST00000317775.11 | c.3925G>A | p.Val1309Ile | missense_variant | 26/29 | 1 | NM_000620.5 | ENSP00000320758.6 | ||
NOS1 | ENST00000338101.8 | c.4027G>A | p.Val1343Ile | missense_variant | 26/29 | 5 | ENSP00000337459.4 | |||
NOS1 | ENST00000618760.4 | c.4027G>A | p.Val1343Ile | missense_variant | 27/30 | 5 | ENSP00000477999.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151878Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
151878
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000401 AC: 10AN: 249530Hom.: 1 AF XY: 0.0000443 AC XY: 6AN XY: 135372
GnomAD3 exomes
AF:
AC:
10
AN:
249530
Hom.:
AF XY:
AC XY:
6
AN XY:
135372
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461868Hom.: 1 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727230
GnomAD4 exome
AF:
AC:
13
AN:
1461868
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
727230
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151996Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74272
GnomAD4 genome
AF:
AC:
6
AN:
151996
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74272
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2024 | The c.4027G>A (p.V1343I) alteration is located in exon 27 (coding exon 26) of the NOS1 gene. This alteration results from a G to A substitution at nucleotide position 4027, causing the valine (V) at amino acid position 1343 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
T;.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
L;.;.;.
PrimateAI
Benign
T
PROVEAN
Benign
N;.;N;.
REVEL
Uncertain
Sift
Benign
T;.;T;.
Sift4G
Benign
T;T;T;T
Polyphen
P;.;.;.
Vest4
MutPred
Gain of catalytic residue at R1311 (P = 0.0646);.;.;.;
MVP
MPC
0.51
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at